Altimmune, Inc. (ALT) Tops Q1 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
• Iridex Corp (IRIX) Misses Q2 EPS by 5c
• Estee Lauder (EL) Tops Q4 EPS by 7c, Beats on Revenue